Welcome to Psychiatryai.com: Latest Evidence - RAISR4D

Mapping the neurovascular landscape in aging and dementia: cerebral small vessel disease markers in a multicenter Latin American cohort

AI Summary
  • Alzheimer's disease showed the highest overall cerebral small vessel disease burden compared with controls and frontotemporal dementia.
  • White matter hyperintensities were the key vascular substrate linked to global and domain-specific cognitive decline.
  • Blood pressure and smoking were the strongest correlates of WMHs, while diabetes was preferentially associated with cerebral microbleeds.
Summarise with AI (MRCPsych/FRANZCP)

Alzheimers Dement. 2026 May;22(5):e71468. doi: 10.1002/alz.71468.

ABSTRACT

INTRODUCTION: Cerebral small vessel disease (CSVD) is a key contributor to cognitive impairment and dementia, yet few studies have compared CSVD across dementia variants, particularly in underrepresented populations.

METHODS: In a multicenter cross-sectional study, we analyzed magnetic resonance imaging (MRI) markers of CSVD, including white matter hyperintensities (WMHs), lacunes, and cerebral microbleeds, along with cardiometabolic risk factors and cognitive performance using regression models in 1675 participants (790 healthy controls, 642 with Alzheimer’s disease [AD], and 243 with frontotemporal dementia [FTD]) from six Latin American countries.

RESULTS: AD showed the greatest CSVD burden, whereas FTD exhibited an intermediate profile driven by elevated WMHs. Blood pressure and smoking were the strongest correlates of WMHs, while diabetes was associated with microbleeds. WMH burden was linked to global and domain-specific cognitive impairment.

DISCUSSION: This first large-cohort Latin American study identifies WMHs as a key vascular substrate of cognitive impairment, with AD showing the greatest CSVD burden.

PMID:42192214 | DOI:10.1002/alz.71468

Document this CPD

AI Search

Share Evidence Blueprint

QR Code

Search Google Scholar

Save as PDF

close chatgpt icon
ChatGPT

Enter your request.

Psychiatry AI: Real-Time AI Scoping Review